Skip to content

Compact Auto-Aligning Multi-Modal Eye Imaging to Diagnose Traumatic Eye Injury

Compact Auto-Aligning Multi -Modal Eye Imaging

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07218835
Enrollment
70
Registered
2025-10-20
Start date
2026-09-01
Completion date
2026-12-30
Last updated
2026-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ocular Pathologies

Brief summary

The purpose of this study is to test an investigational eye imaging device by taking pictures of participants eyes with a single image capture that takes only seconds.

Interventions

DEVICEAuto-aligning Ocular imaging instrument

Develop a tri-modality, auto-aligning ocular imaging instrument incorporating gross color photography, anterior and posterior segment OCT in a compact, handheld form factor.

Sponsors

Duke University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Ocular complaints potentially indicating anterior segment pathology (e.g., corneal abrasions, corneal edema, corneal scars) * Ocular complaints potentially indicating posterior segment pathology (e.g., macular edema, neovascular, macular degeneration)

Exclusion criteria

* Participant is unable to be imaged for any reason

Design outcomes

Primary

MeasureTime frameDescription
Number of participants who found the eye imaging device easy to useup to 2 years
Number of participants who found the eye imaging device mobileup to 2 years
Number of participants who found the eye imaging device reliableup to 2 years
Image quality as measured by the number of eye condition diagnoses that match official diagnosesup to 2 yearsDiagnoses made from the eye imaging device will be compared to the official diagnoses the patients received from a full eye exam in the clinic or emergency department.

Countries

United States

Contacts

CONTACTTeresa Hawks
teresa.hawks@duke.edu919-681-1569
PRINCIPAL_INVESTIGATORAnthony Kuo, MD

Duke University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026